Last updated: April 24, 2026

Application No. 19/336,364

Untitled Application

Unknown

Filed

1600

Examiner

KOSTURKO, GEORGE W

Art Unit

1621

Tech Center

PHARMA MAR, S.A.

Assignee

Pharma Mar S A

OA Round

1 (Non-Final)

This examiner grants 54% of cases after interview

— +49.1% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 699 resolved cases, 2023–2026

Examiner Intelligence

KOSTURKO, GEORGE W View full profile →

Grants 54% of resolved cases

Career Allow Rate

379 granted / 699 resolved

-5.8% vs TC avg

Strong +49% interview lift

Without

With

+49.1%

Interview Lift

resolved cases with interview

Typical timeline

2y 8m

Avg Prosecution

54 currently pending

Career history

753

Total Applications

across all art units

Statute-Specific Performance

§101

1.1%

-38.9% vs TC avg

§103

40.4%

+0.4% vs TC avg

§102

17.7%

-22.3% vs TC avg

§112

21.7%

-18.3% vs TC avg

Black line = Tech Center average estimate • Based on career data from 699 resolved cases

Prosecution Timeline

1600

Application Filed

Feb 11, 2026

Non-Final Rejection

Mar 23, 2026

Response Filed

Precedent Cases

Applications granted by this same examiner with similar technology

18/555,659

Patent 12595237

LAMOTRIGINE HYDRATE CRYSTAL FORM, PREPARATION METHOD THEREFOR, AND COMPOSITION CONTAINING SAME

2y 5m to grant Granted Apr 07, 2026

18/590,002

Patent 12589094

CONCOMITANT ADMINISTRATION OF GLUCOCORTICOID RECEPTOR MODULATOR RELACORILANT AND PACLITAXEL, A DUAL SUBSTRATE OF CYP2C8 AND CYP3A4

2y 5m to grant Granted Mar 31, 2026

17/417,201

Patent 12577217

15-PGDH INHIBITOR

2y 5m to grant Granted Mar 17, 2026

18/468,453

Patent 12576088

Methods for Enhancing Cytotoxic Cancer Therapy Through Inhibition of ATG4B

2y 5m to grant Granted Mar 17, 2026

17/442,726

Patent 12570679

STAT3 PROTEIN DEGRADERS

2y 5m to grant Granted Mar 10, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.

Prosecution Projections

1-2

Expected OA Rounds

54%

Grant Probability

99%

With Interview (+49.1%)

2y 8m

Median Time to Grant

Low

PTA Risk

Based on 699 resolved cases by this examiner. Grant probability derived from career allow rate.